chr3-10036271-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001018115.3(FANCD2):c.439-16A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.167 in 1,597,844 control chromosomes in the GnomAD database, including 23,933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.20   (  3423   hom.,  cov: 29) 
 Exomes 𝑓:  0.16   (  20510   hom.  ) 
Consequence
 FANCD2
NM_001018115.3 intron
NM_001018115.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.723  
Publications
19 publications found 
Genes affected
 FANCD2  (HGNC:3585):  (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016] 
FANCD2 Gene-Disease associations (from GenCC):
- Fanconi anemia complementation group D2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BP6
Variant 3-10036271-A-G is Benign according to our data. Variant chr3-10036271-A-G is described in ClinVar as Benign. ClinVar VariationId is 257083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.315  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.197  AC: 29682AN: 151020Hom.:  3419  Cov.: 29 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
29682
AN: 
151020
Hom.: 
Cov.: 
29
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.162  AC: 40657AN: 251320 AF XY:  0.161   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
40657
AN: 
251320
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.163  AC: 236401AN: 1446706Hom.:  20510  Cov.: 29 AF XY:  0.163  AC XY: 117783AN XY: 720572 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
236401
AN: 
1446706
Hom.: 
Cov.: 
29
 AF XY: 
AC XY: 
117783
AN XY: 
720572
show subpopulations 
African (AFR) 
 AF: 
AC: 
10890
AN: 
32988
American (AMR) 
 AF: 
AC: 
7031
AN: 
44632
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
4053
AN: 
26018
East Asian (EAS) 
 AF: 
AC: 
2244
AN: 
39630
South Asian (SAS) 
 AF: 
AC: 
15362
AN: 
85934
European-Finnish (FIN) 
 AF: 
AC: 
6564
AN: 
53210
Middle Eastern (MID) 
 AF: 
AC: 
930
AN: 
5720
European-Non Finnish (NFE) 
 AF: 
AC: 
179478
AN: 
1098726
Other (OTH) 
 AF: 
AC: 
9849
AN: 
59848
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.440 
Heterozygous variant carriers
 0 
 9318 
 18636 
 27954 
 37272 
 46590 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 6422 
 12844 
 19266 
 25688 
 32110 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.197  AC: 29707AN: 151138Hom.:  3423  Cov.: 29 AF XY:  0.191  AC XY: 14124AN XY: 73832 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
29707
AN: 
151138
Hom.: 
Cov.: 
29
 AF XY: 
AC XY: 
14124
AN XY: 
73832
show subpopulations 
African (AFR) 
 AF: 
AC: 
13125
AN: 
41032
American (AMR) 
 AF: 
AC: 
2189
AN: 
15182
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
522
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
338
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
765
AN: 
4786
European-Finnish (FIN) 
 AF: 
AC: 
1202
AN: 
10438
Middle Eastern (MID) 
 AF: 
AC: 
38
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
10927
AN: 
67770
Other (OTH) 
 AF: 
AC: 
358
AN: 
2102
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.462 
Heterozygous variant carriers
 0 
 1001 
 2002 
 3002 
 4003 
 5004 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 316 
 632 
 948 
 1264 
 1580 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
403
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:8 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Fanconi anemia complementation group D2    Benign:3 
Nov 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:2 
Feb 11, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Fanconi anemia    Benign:1 
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hereditary breast ovarian cancer syndrome    Benign:1 
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.